These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 7643617)

  • 1. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).
    Domer PH; Head DR; Renganathan N; Raimondi SC; Yang E; Atlas M
    Leukemia; 1995 Aug; 9(8):1305-12. PubMed ID: 7643617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.
    Broeker PL; Super HG; Thirman MJ; Pomykala H; Yonebayashi Y; Tanabe S; Zeleznik-Le N; Rowley JD
    Blood; 1996 Mar; 87(5):1912-22. PubMed ID: 8634439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region.
    Strissel PL; Strick R; Rowley JD; Zeleznik-Le NJ
    Blood; 1998 Nov; 92(10):3793-803. PubMed ID: 9808573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
    Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
    Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MLL genomic breakpoint distribution within the breakpoint cluster region in de novo leukemia in children.
    Felix CA; Hosler MR; Slater DJ; Parker RI; Masterson M; Whitlock JA; Rebbeck TR; Nowell PC; Lange BJ
    J Pediatr Hematol Oncol; 1998; 20(4):299-308. PubMed ID: 9703001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rearrangements involving chromosome band 11Q23 in acute leukaemia.
    Rowley JD
    Semin Cancer Biol; 1993 Dec; 4(6):377-85. PubMed ID: 8142623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children.
    Felix CA; Hosler MR; Winick NJ; Masterson M; Wilson AE; Lange BJ
    Blood; 1995 Jun; 85(11):3250-6. PubMed ID: 7756657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.
    Rowley JD; Reshmi S; Sobulo O; Musvee T; Anastasi J; Raimondi S; Schneider NR; Barredo JC; Cantu ES; Schlegelberger B; Behm F; Doggett NA; Borrow J; Zeleznik-Le N
    Blood; 1997 Jul; 90(2):535-41. PubMed ID: 9226152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors.
    Aplan PD; Chervinsky DS; Stanulla M; Burhans WC
    Blood; 1996 Apr; 87(7):2649-58. PubMed ID: 8639880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A DNA probe combination for improved detection of MLL/11q23 breakpoints by double-color interphase-FISH in acute leukemias.
    von Bergh A; Emanuel B; van Zelderen-Bhola S; Smetsers T; van Soest R; Stul M; Vranckx H; Schuuring E; Hagemeijer A; Kluin P
    Genes Chromosomes Cancer; 2000 May; 28(1):14-22. PubMed ID: 10738298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site.
    Slater DJ; Hilgenfeld E; Rappaport EF; Shah N; Meek RG; Williams WR; Lovett BD; Osheroff N; Autar RS; Ried T; Felix CA
    Oncogene; 2002 Jul; 21(30):4706-14. PubMed ID: 12096348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of genomic breakpoints in MLL and CBP in leukemia patients with t(11;16).
    Zhang Y; Zeleznik-Le N; Emmanuel N; Jayathilaka N; Chen J; Strissel P; Strick R; Li L; Neilly MB; Taki T; Hayashi Y; Kaneko Y; Schlegelberger B; Rowley JD
    Genes Chromosomes Cancer; 2004 Nov; 41(3):257-65. PubMed ID: 15334549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias.
    Cimino G; Rapanotti MC; Biondi A; Elia L; Lo Coco F; Price C; Rossi V; Rivolta A; Canaani E; Croce CM; Mandelli F; Greaves M
    Cancer Res; 1997 Jul; 57(14):2879-83. PubMed ID: 9230194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
    Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
    Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.
    Langer T; Metzler M; Reinhardt D; Viehmann S; Borkhardt A; Reichel M; Stanulla M; Schrappe M; Creutzig U; Ritter J; Leis T; Jacobs U; Harbott J; Beck JD; Rascher W; Repp R
    Genes Chromosomes Cancer; 2003 Apr; 36(4):393-401. PubMed ID: 12619163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites.
    Felix CA; Lange BJ; Hosler MR; Fertala J; Bjornsti MA
    Cancer Res; 1995 Oct; 55(19):4287-92. PubMed ID: 7671237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.
    Lovett BD; Lo Nigro L; Rappaport EF; Blair IA; Osheroff N; Zheng N; Megonigal MD; Williams WR; Nowell PC; Felix CA
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9802-7. PubMed ID: 11493704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation.
    Corral J; Forster A; Thompson S; Lampert F; Kaneko Y; Slater R; Kroes WG; van der Schoot CE; Ludwig WD; Karpas A
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8538-42. PubMed ID: 8378328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias.
    Megonigal MD; Rappaport EF; Jones DH; Kim CS; Nowell PC; Lange BJ; Felix CA
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11583-8. PubMed ID: 9326653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and sequence analysis of four t(9;11) therapy-related leukemia breakpoints.
    Atlas M; Head D; Behm F; Schmidt E; Zeleznik-Le NH; Roe BA; Burian D; Domer PH
    Leukemia; 1998 Dec; 12(12):1895-902. PubMed ID: 9844920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.